1973
DOI: 10.1007/bf00595531
|View full text |Cite
|
Sign up to set email alerts
|

Tryptophan ? niacin pathway in scleroderma and in dermatomyositis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

1975
1975
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(5 citation statements)
references
References 3 publications
0
4
0
Order By: Relevance
“…Additional cases of SSc-like illness were reported after exposure to 5-HTP, carbidopa, 108 and other alterations in tryptophan metabolism. [109][110][111] Anecdotal reports of SSc-like cutaneous disease were described with appetite suppressants (eg, dexamphetamine), 112 pentazocine, 113,114 penicillamine, 115 bromocriptine, 116 methylphenidate, 117 local anesthetic, 118 and estrogen. 119,120 Vitamin K injection has been associated with a morphea-like reaction, Texier's disease.…”
Section: Chemotherapeutic Agentsmentioning
confidence: 99%
See 1 more Smart Citation
“…Additional cases of SSc-like illness were reported after exposure to 5-HTP, carbidopa, 108 and other alterations in tryptophan metabolism. [109][110][111] Anecdotal reports of SSc-like cutaneous disease were described with appetite suppressants (eg, dexamphetamine), 112 pentazocine, 113,114 penicillamine, 115 bromocriptine, 116 methylphenidate, 117 local anesthetic, 118 and estrogen. 119,120 Vitamin K injection has been associated with a morphea-like reaction, Texier's disease.…”
Section: Chemotherapeutic Agentsmentioning
confidence: 99%
“…Additional cases of SSc-like illness were reported after exposure to 5-HTP, carbidopa, 108 and other alterations in tryptophan metabolism. 109 -111…”
Section: Exposures With Probable Association (Level III Evidence)mentioning
confidence: 99%
“…Excretion of TRP, KYN, and KYNA in the urine was not studied in our study. Since previous publications indicate increased urinary excretion of KYN and KYNA in SSc patients [10][11][12], it cannot be excluded that the results of measuring the current level of KP metabolites in the blood do not provide a complete picture of the processes occurring in the affected tissues. Considering that KYN excretion is increased, and yet the KYN level in the blood does not change, as is the case in women with SSc, it can be presumed that KYN production is in fact elevated, at least by an amount to compensate for increased urine excretion of KYN.…”
Section: Study Limitationsmentioning
confidence: 99%
“…To this end, the main aim of this study is to examine the sex-related differences in the KP in SSc patients considering the peripheral concentrations of TRP, KYNA, and KYN as well as kynurenine pathway enzyme activity indicators, indoleamine 2,3-dioxygenase In recent decades, there has been increasing discussion about the role of KP metabolites in SSc [5][6][7], as these metabolites are closely associated with inflammation [8]. Previous studies in SSc patients have shown an increase in the urinary excretion of certain TRP metabolites, particularly kynurenine (KYN), which allowed formulation of the hypothesis regarding dysregulation of TRP metabolism in SSc [9][10][11][12]. Furthermore, other studies revealed that metabolites of TRP formed along KP, specifically KYN and kynurenic acid (KYNA), have been found to inhibit fibroblast metabolism and proliferation and alleviate fibrosis [13,14].…”
Section: Introductionmentioning
confidence: 99%
“…41) prompt ed a fe\\ investigations on TRY metabolism in the serotonin and 5-hydroxyindolc-acetic acid (5-HIAA) path way (6,38). Subsequent studies on scleroderma were concerned mainly with the kynurenine-nia cin pathways of TRY metabolism (4,16,18,36).…”
mentioning
confidence: 99%